Clinical Trials Directory

Trials / Completed

CompletedNCT02257957

Platelet -Rich Plasma (PRP) Injection for the Treatment of Severe Dry Eye

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Universidad Nacional de Colombia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Dry eye is a chronic condition that decreases function and affect visual function with severe discapacity until now treatments are based in artificial eye drops. Platelet rich plasma has emerged as a strategy for cellular restoration, the purpose of this study is to evaluate their effects in lacrimal production and safety of this intervention in patients with severe dry eye.

Detailed description

Dry eye is a chronic condition that decreases function and affect visual function with severe discapacity until now treatments are based in artificial eye drops. Platelet rich plasma has emerged as a strategy for cellular restoration, the purpose of this study is to evaluate their effects in lacrimal production and safety of this intervention in patients with severe dry eye.

Conditions

Interventions

TypeNameDescription
DRUGPRP injection
DRUGStandard care Hyaluronic acid eye drops: 15 patients with diagnosis of severe dry eye will receive standard of care treatment ( Hyaluronic acid eye drops 5 times per day). Objective measurements as corneal staining, Shirmer , BUT, and VA, will be determinate as subjective measurements as OSDI and treatment compliance will be evaluated at day 0-30,60 and 90

Timeline

Start date
2014-11-30
Primary completion
2015-09-30
Completion
2016-04-20
First posted
2014-10-07
Last updated
2021-08-24
Results posted
2021-08-24

Source: ClinicalTrials.gov record NCT02257957. Inclusion in this directory is not an endorsement.